This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
SUMMARY
- STELARA solution for intravenous infusion must be infused by a healthcare professional only and is given as an induction therapy for the treatment of Crohn’s disease and ulcerative colitis. It is to be diluted prior to intravenous infusion and administered over at least 1 hour according to the DOSAGE AND ADMINISTRATION section of the STELARA full Prescribing Information.1
DOSAGE AND ADMINISTRATION
Preparation and Administration of STELARA 130 mg/26 mL (5 mg/mL) Vial for Intravenous Infusion (Crohn’s disease and Ulcerative Colitis)
STELARA solution for intravenous infusion must be diluted, prepared and infused by a healthcare professional using aseptic technique.1
- Calculate the dose and the number of STELARA vials needed based on patient weight (Please see Tables 4, 5, 6, and 7 in the full Prescribing Information). Each 26 mL vial of STELARA contains 130 mg of ustekinumab.
- Obtain the appropriate infusion solution (see table below). Withdraw and discard a volume of the infusion solution equal to the volume of STELARA solution to be added. For appropriate infusion solution see Table: Appropriate Infusion Solution and Final Infusion Volumes for Intravenous Infusion of STELARA Solution.
Appropriate Infusion Solution and Final Infusion Volumes for Intravenous Infusion of STELARA Solution1
|
|
|
|
|---|
Pediatric
| 10 kg to 25 kg
| 0.9% Sodium Chloride Injection
| 100 mLa
|
Pediatric
| Greater than 25 kg
| 0.9% Sodium Chloride Injection
| 250 mLa
|
Adult
| All weights
| 0.45% or 0.9% Sodium Chloride Injection
| 250 mLa
|
aRemove a volume of infusion solution equal to the volume of STELARA solution to be added to obtain the final volume.
|
- Add the volume of STELARA solution equal to the calculated dose of STELARA to the infusion solution and gently mix.
- Visually inspect the diluted solution before infusion. Do not use if visibly opaque particles, discoloration or foreign particles are observed.
- Infuse the diluted solution over a period of at least one hour. Once diluted, the infusion should be completely administered within the storage time (see Storage below).
- Use only an infusion set with an in-line, sterile, non-pyrogenic, low protein-binding filter (pore size 0.2 micrometer).
- Do not infuse STELARA concomitantly in the same intravenous line with other agents.
- STELARA does not contain preservatives. Each vial is for single use only. Discard any remaining solution. Dispose any unused medicinal product in accordance with local requirements.
- Discard any unused portion of the infusion.
Storage
- Do not freeze.
- Storage time at room temperature begins once the diluted solution has been prepared.
100 mL infusion bag:
- If necessary, the diluted infusion solution may be kept at room temperature up to 25 °C (77 °F) for up to 3 hours.
- The infusion should be completed within 4 hours after the dilution in the infusion bag (cumulative time after preparation including the storage and the infusion period).
250 mL infusion bag:
- If necessary, the diluted infusion solution may be kept at room temperature up to 25 °C (77 °F) for up to 7 hours.
- The infusion should be completed within 8 hours after the dilution in the infusion bag (cumulative time after preparation including the storage and the infusion period).